JMP Securities Maintains Market Outperform on Pharvaris, Raises Price Target to $49
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Jonathan Wolleben has maintained a Market Outperform rating on Pharvaris (NASDAQ:PHVS) and increased the price target from $40 to $49.
January 23, 2024 | 1:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JMP Securities analyst has reaffirmed Pharvaris with a Market Outperform rating and raised the price target from $40 to $49.
The increase in price target by JMP Securities suggests a positive outlook on Pharvaris, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100